Meticet Syrup contains Levocetirizine at a concentration of 2.5 mg per 5 ml and is an effective second-generation antihistamine indicated for the relief of symptoms associated with allergic conditions such as seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. Levocetirizine, the active enantiomer of cetirizine, selectively inhibits peripheral H1 histamine receptors, thereby reducing the effects of histamine responsible for allergy symptoms including sneezing, nasal congestion, rhinorrhea, itching, and hives. Meticet Syrup is formulated for oral administration, offering a convenient dosing option particularly suitable for pediatric and adult patients who require symptomatic relief from allergic manifestations. The medication is characterized by a rapid onset of action and a favorable safety profile, with minimal sedative effects compared to first-generation antihistamines. It is recommended to be taken once daily, with dosage adjustments based on age and clinical response. Caution is advised in patients with renal impairment, and use during pregnancy or lactation should be under medical supervision. Common adverse effects may include mild drowsiness, dry mouth, and fatigue. Meticet Syrup should be used as directed by a healthcare professional to ensure optimal therapeutic outcomes.